Show simple item record

dc.contributor.authorWarris, Adilia
dc.contributor.authorLehrnbecher, Thomas
dc.contributor.authorRoilides, Emmanuel
dc.contributor.authorCastagnola, Elio
dc.contributor.authorBruggemann, Roger J. M.
dc.contributor.authorGroll, Andreas H.
dc.date.accessioned2020-05-30T23:06:21Z
dc.date.available2020-05-30T23:06:21Z
dc.date.issued2019-09
dc.identifier.citationWarris , A , Lehrnbecher , T , Roilides , E , Castagnola , E , Bruggemann , R J M & Groll , A H 2019 , ' ESCMID-ECMM guideline : diagnosis and management of invasive aspergillosis in neonates and children ' , Clinical Microbiology and Infection , vol. 25 , no. 9 , pp. 1096-1113 . https://doi.org/10.1016/j.cmi.2019.05.019en
dc.identifier.issn1198-743X
dc.identifier.otherPURE: 144385393
dc.identifier.otherPURE UUID: af5eb782-9701-4ccc-a919-497d0bcaecff
dc.identifier.otherScopus: 85067697628
dc.identifier.otherMendeley: 5073cf82-27cb-323c-892e-cdb6a6fe9f2b
dc.identifier.otherORCID: /0000-0001-6586-3358/work/58864087
dc.identifier.otherWOS: 000481643000008
dc.identifier.urihttps://hdl.handle.net/2164/14403
dc.descriptionACKNOWLEDGEMENT Prof Warris is supported by the Wellcome Trust Strategic Award (grant 097377) and the MRC Centre for Medical Mycology (grant MR/N006364/1) at the University of Aberdeen. FUNDING European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the European Confederation of Medical Mycology (ECMM)en
dc.format.extent18
dc.language.isoeng
dc.relation.ispartofClinical Microbiology and Infectionen
dc.rights© 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectantifungal prophylaxisen
dc.subjectantifungal therapyen
dc.subjectaspergillosisen
dc.subjectneonates,childrenen
dc.subjectAntifungal therapyen
dc.subjectNeonatesen
dc.subjectAspergillosisen
dc.subjectAntifungal prophylaxisen
dc.subjectChildrenen
dc.subjectBRONCHOALVEOLAR LAVAGE GALACTOMANNANen
dc.subjectPOPULATION PHARMACOKINETIC ANALYSISen
dc.subjectCHRONIC GRANULOMATOUS-DISEASEen
dc.subjectEMPIRICAL ANTIFUNGAL THERAPYen
dc.subjectBETA-D-GLUCANen
dc.subjectLIPOSOMAL AMPHOTERICIN-Ben
dc.subjectPEDIATRIC CANCER-PATIENTSen
dc.subjectPOLYMERASE-CHAIN-REACTIONen
dc.subjectITRACONAZOLE ORAL SOLUTIONen
dc.subjectSTEM-CELL TRANSPLANTATIONen
dc.subjectRJ Pediatricsen
dc.subjectMicrobiology (medical)en
dc.subjectInfectious Diseasesen
dc.subjectMedical Research Council (MRC)en
dc.subjectMR/N006364/1en
dc.subjectWellcome Trusten
dc.subject097377en
dc.subject.lccRJen
dc.titleESCMID-ECMM guideline : diagnosis and management of invasive aspergillosis in neonates and childrenen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.MRC Centre for Medical Mycologyen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.description.statusPeer revieweden
dc.description.versionPostprinten
dc.description.versionPostprinten
dc.identifier.doihttps://doi.org/10.1016/j.cmi.2019.05.019
dc.date.embargoedUntil2020-05-31
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85067697628&partnerID=8YFLogxKen
dc.identifier.urlhttps://linkinghub.elsevier.com/retrieve/pii/S1198743X19302824en
dc.identifier.urlhttp://www.mendeley.com/research/escmidecmm-guideline-diagnosis-management-invasive-aspergillosis-neonates-childrenen
dc.identifier.urlhttp://europepmc.org/abstract/med/31158517en
dc.identifier.vol25en
dc.identifier.iss9en


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record